Labcorp Holdings, Inc. (LH)
335.11
-1.43
(-0.42%)
USD |
NYSE |
Aug 28, 16:00
335.10
-0.02
(-0.00%)
After-Hours: 20:00
Labcorp Holdings Free Cash Flow : 1.155B for June 30, 2026
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2026 | 1.155B |
| March 31, 2026 | 1.384B |
| December 31, 2025 | 1.206B |
| September 30, 2025 | 1.381B |
| June 30, 2025 | 1.262B |
| March 31, 2025 | 1.152B |
| December 31, 2024 | 1.096B |
| September 30, 2024 | 843.20M |
| June 30, 2024 | 852.30M |
| March 31, 2024 | 667.50M |
| December 31, 2023 | 874.10M |
| September 30, 2023 | 1.016B |
| June 30, 2023 | 1.137B |
| March 31, 2023 | 1.331B |
| December 31, 2022 | 1.527B |
| September 30, 2022 | 1.520B |
| June 30, 2022 | 1.878B |
| March 31, 2022 | 1.826B |
| December 31, 2021 | 2.649B |
| September 30, 2021 | 2.777B |
| June 30, 2021 | 2.836B |
| March 31, 2021 | 2.719B |
| December 31, 2020 | 1.754B |
| September 30, 2020 | 954.50M |
| June 30, 2020 | 802.90M |
| Date | Value |
|---|---|
| March 31, 2020 | 810.40M |
| December 31, 2019 | 1.044B |
| September 30, 2019 | 1.533B |
| June 30, 2019 | 1.174B |
| March 31, 2019 | 1.175B |
| December 31, 2018 | 925.60M |
| September 30, 2018 | 1.030B |
| June 30, 2018 | 1.152B |
| March 31, 2018 | 1.112B |
| December 31, 2017 | 1.183B |
| September 30, 2017 | 1.089B |
| June 30, 2017 | 950.90M |
| March 31, 2017 | 993.30M |
| December 31, 2016 | 897.00M |
| September 30, 2016 | 821.90M |
| June 30, 2016 | 858.40M |
| March 31, 2016 | 903.50M |
| December 31, 2015 | 726.60M |
| September 30, 2015 | 570.50M |
| June 30, 2015 | 473.30M |
| March 31, 2015 | 304.90M |
| December 31, 2014 | 511.40M |
| September 30, 2014 | 557.10M |
| June 30, 2014 | 616.20M |
| March 31, 2014 | 545.80M |
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Quest Diagnostics, Inc. | 1.349B |
| DaVita, Inc. | 1.610B |
| CVS Health Corp. | 11.76B |
| OPKO Health, Inc. | -134.02M |
| Psychemedics Corp. | -- |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 445.50M |
| Cash from Investing (Quarterly) | -366.20M |
| Cash from Financing (Quarterly) | -919.90M |
| Free Cash Flow Per Share (Quarterly) | 3.828 |
| Free Cash Flow to Equity (Quarterly) | 788.40M |
| Free Cash Flow to Firm (Quarterly) | 361.20M |
| Free Cash Flow Yield | 4.16% |